Search

Howard J Sanders

Examiner (ID: 15220, Phone: (571)270-3096 , Office: P/3653 )

Most Active Art Unit
3653
Art Unit(s)
3658, 3653
Total Applications
914
Issued Applications
683
Pending Applications
65
Abandoned Applications
166

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16483840 [patent_doc_number] => 20200377441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => METHODS OF PROTECTING AN ORGAN USING TETRAHYDROCURCUMIN AND PHOSPHATIDYLCHOLINE [patent_app_type] => utility [patent_app_number] => 16/997255 [patent_app_country] => US [patent_app_date] => 2020-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49313 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997255 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/997255
METHODS OF PROTECTING AN ORGAN USING TETRAHYDROCURCUMIN AND PHOSPHATIDYLCHOLINE Aug 18, 2020 Pending
Array ( [id] => 17697071 [patent_doc_number] => 11370781 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-28 [patent_title] => Combination therapy for treating cancer [patent_app_type] => utility [patent_app_number] => 16/985404 [patent_app_country] => US [patent_app_date] => 2020-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 38794 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 291 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16985404 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/985404
Combination therapy for treating cancer Aug 4, 2020 Issued
Array ( [id] => 16569091 [patent_doc_number] => 20210008097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => Compositions Comprising Galactose-Pronged Polysaccharides [patent_app_type] => utility [patent_app_number] => 16/983760 [patent_app_country] => US [patent_app_date] => 2020-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8465 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16983760 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/983760
Compositions Comprising Galactose-Pronged Polysaccharides Aug 2, 2020 Abandoned
Array ( [id] => 17620149 [patent_doc_number] => 11339187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-24 [patent_title] => Process for the preparation of GalNAc oligonucleotide conjugates [patent_app_type] => utility [patent_app_number] => 16/939849 [patent_app_country] => US [patent_app_date] => 2020-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5916 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939849 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/939849
Process for the preparation of GalNAc oligonucleotide conjugates Jul 26, 2020 Issued
Array ( [id] => 16437071 [patent_doc_number] => 20200354397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => PHOSPHORAMIDITE SYNTHONES FOR THE SYNTHESIS OF SELF-NEUTRALIZING OLIGONUCLEOTIDE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/940039 [patent_app_country] => US [patent_app_date] => 2020-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13835 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16940039 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/940039
Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compounds Jul 26, 2020 Issued
Array ( [id] => 16619976 [patent_doc_number] => 20210038629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => COMPOUNDS AND METHODS FOR MODULATING GFAP [patent_app_type] => utility [patent_app_number] => 16/938826 [patent_app_country] => US [patent_app_date] => 2020-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56287 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938826 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/938826
Compounds and methods for modulating GFAP Jul 23, 2020 Issued
Array ( [id] => 16569083 [patent_doc_number] => 20210008089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER [patent_app_type] => utility [patent_app_number] => 16/929690 [patent_app_country] => US [patent_app_date] => 2020-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10943 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16929690 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/929690
COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER Jul 14, 2020 Abandoned
Array ( [id] => 16791669 [patent_doc_number] => 20210121486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/921562 [patent_app_country] => US [patent_app_date] => 2020-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50325 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16921562 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/921562
ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE Jul 5, 2020 Abandoned
Array ( [id] => 16523727 [patent_doc_number] => 20200397807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => NICOTINYL RIBOSIDE COMPOUNDS AND THEIR USES [patent_app_type] => utility [patent_app_number] => 16/904270 [patent_app_country] => US [patent_app_date] => 2020-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904270 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/904270
NICOTINYL RIBOSIDE COMPOUNDS AND THEIR USES Jun 16, 2020 Abandoned
Array ( [id] => 17421482 [patent_doc_number] => 11254927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-22 [patent_title] => Polynucleotide capture materials, and systems using same [patent_app_type] => utility [patent_app_number] => 16/890752 [patent_app_country] => US [patent_app_date] => 2020-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13461 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890752 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/890752
Polynucleotide capture materials, and systems using same Jun 1, 2020 Issued
Array ( [id] => 16297823 [patent_doc_number] => 20200283546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => Method for Preparing Short-Clustered Dextrin [patent_app_type] => utility [patent_app_number] => 16/884340 [patent_app_country] => US [patent_app_date] => 2020-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5591 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884340 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/884340
Method for preparing short-clustered dextrin May 26, 2020 Issued
Array ( [id] => 17828388 [patent_doc_number] => 20220265692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => ORALLY-ADMINISTERED PHARMACEUTICAL COMPOSITION FOR ERADICATING ANTIBIOTIC-RESISTANT HELICOBACTER PYLORI, COMPRISING COMPLEX OF NON-ABSORBABLE ANTIBIOTIC AND CLAY MINERAL [patent_app_type] => utility [patent_app_number] => 17/620585 [patent_app_country] => US [patent_app_date] => 2020-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9054 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620585 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/620585
ORALLY-ADMINISTERED PHARMACEUTICAL COMPOSITION FOR ERADICATING ANTIBIOTIC-RESISTANT HELICOBACTER PYLORI, COMPRISING COMPLEX OF NON-ABSORBABLE ANTIBIOTIC AND CLAY MINERAL May 21, 2020 Pending
Array ( [id] => 16282615 [patent_doc_number] => 20200276217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => Application of Macrolide Antibiotic in Blocking Influenza Virus Infection [patent_app_type] => utility [patent_app_number] => 16/880414 [patent_app_country] => US [patent_app_date] => 2020-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5691 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16880414 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/880414
Application of Macrolide Antibiotic in Blocking Influenza Virus Infection May 20, 2020 Abandoned
Array ( [id] => 16268723 [patent_doc_number] => 20200270210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => CHEMICAL COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/872949 [patent_app_country] => US [patent_app_date] => 2020-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20928 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16872949 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/872949
Chemical compounds May 11, 2020 Issued
Array ( [id] => 16583168 [patent_doc_number] => 20210017570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => DETECTION OF OLIGOSACCHARIDES [patent_app_type] => utility [patent_app_number] => 16/866397 [patent_app_country] => US [patent_app_date] => 2020-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22418 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866397 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/866397
DETECTION OF OLIGOSACCHARIDES May 3, 2020 Abandoned
Array ( [id] => 16435643 [patent_doc_number] => 20200352968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => METHODS FOR REDUCING THE WEIGHT LOSS OR INCREASING THE WEIGHT OF A FELINE IN NEED THEREOF [patent_app_type] => utility [patent_app_number] => 16/856342 [patent_app_country] => US [patent_app_date] => 2020-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12722 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16856342 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/856342
METHODS FOR REDUCING THE WEIGHT LOSS OR INCREASING THE WEIGHT OF A FELINE IN NEED THEREOF Apr 22, 2020 Abandoned
Array ( [id] => 16688741 [patent_doc_number] => 20210071217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => GELLING DEXTRAN ETHERS [patent_app_type] => utility [patent_app_number] => 16/856559 [patent_app_country] => US [patent_app_date] => 2020-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16856559 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/856559
GELLING DEXTRAN ETHERS Apr 22, 2020 Abandoned
Array ( [id] => 16452917 [patent_doc_number] => 20200362343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT [patent_app_type] => utility [patent_app_number] => 16/853670 [patent_app_country] => US [patent_app_date] => 2020-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45840 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853670 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/853670
METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT Apr 19, 2020 Abandoned
Array ( [id] => 16204804 [patent_doc_number] => 20200237794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS [patent_app_type] => utility [patent_app_number] => 16/844522 [patent_app_country] => US [patent_app_date] => 2020-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19148 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16844522 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/844522
TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS Apr 8, 2020 Pending
16/838972 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY Apr 1, 2020
Menu